Pfizer Inc. (NYSE: PFE) announced today the completion of a global, ex-China, licensing agreement with 3SBio, Inc. (01530.HK) ...

Pfizer is cutting costs, growing its core business, and trading at a deep discount despite looming patent losses and COVID ...

Pfizer is positioning for a potential long-term rebound following a steep post-COVID revenue decline and a drop of over 50% ...

Pfizer Inc. continues to showcase potential practice-changing research and next-generation candidates across its robust Oncology portfolio at the European Society for Medical Oncology Congress ...

Suneet Varma, Global Oncology & U.S. President at Pfizer, tells SurvivorNet that the company aims to continue making progress related to improving cancer screening rates by leveraging technology ...

Pfizer is laying down new pieces for its leadership team structure, selecting Jeffrey Legos, Ph.D., to replace interim Chief Oncology Officer Roger Dansey, M.D. As head of oncology, Legos will ...

Pfizer’s chief oncology officer, Chris Boshoff, M.D., Ph.D., announced the move Friday on LinkedIn. Filling Varma’s position will be Tina Deignan, Ph.D., who was most recently a senior VP ...

De-Escalation Strategies With Immune Checkpoint Blockers in Non–Small Cell Lung Cancer: Do We Already Have Enough Evidence? ... Speakers' Bureau: AstraZeneca, Bristol Myers Squibb/Pfizer, MSD Oncology ...